Farabi Pharmaceutical (XTEH:DFRB1) Inventories, Finished Goods: IRR0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Farabi Pharmaceutical Inventories, Finished Goods?

Farabi Pharmaceutical XTEH:DFRB1 Inventories, Finished Goods is IRR0.00 Mil as of . 20.

Farabi Pharmaceutical Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Inventories, Finished Goods Chart

Farabi Pharmaceutical Annual Data
Trend
Inventories, Finished Goods

Farabi Pharmaceutical Quarterly Data
Inventories, Finished Goods

Farabi Pharmaceutical Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Inventories, Finished Goods of IRR0.00 Mil as of . 20. Finished goods are inventory items that are complete and ready to be sold. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Inventories, Finished Goods too high?
Farabi Pharmaceutical's current Inventories, Finished Goods is IRR0.00 Mil.
How does Farabi Pharmaceutical's Inventories, Finished Goods compare to IMNPQ and INNV?
Farabi Pharmaceutical's Inventories, Finished Goods of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Inventories, Finished Goods is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Inventories, Finished Goods of IRR0.00 Mil. The current Inventories, Finished Goods is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Inventories, Finished Goods is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.